A groundbreaking study from Oklahoma State University highlights how neuroblastoma cells manage to dodge the immune system’s defenses. The research pinpoints a crucial protein, RD3, that plays a key role in controlling how these tumor cells behave and interact with immune responses. When RD3 is lost, neuroblastoma cells adapt, becoming harder to eliminate through treatments.
